Skip to main content

Table 1 General conditions and outcomes of patients with ECMO therapy

From: Application of extracorporeal membrane oxygenation in patients with severe acute respiratory distress syndrome induced by avian influenza A (H7N9) viral pneumonia: national data from the Chinese multicentre collaboration

Variable

Total (n = 35)

Successfully weaned group (n = 14)

Unsuccessfully weaned group (n = 21)

P value

Gender, number (%)

 Male

23(65.7)

9(64.3)

14(66.7)

1.00

Age, years, mean ± SD

57 ± 1

51 ± 10

60 ± 12

0.02*

Underlying Diseases, number (%)

 Hypertension

19(54.3)

7(50)

12(57.1)

0.74

 Diabetes

13(37.1)

1(7.1)

12(57.1)

< 0.01*

 Cerebrovascular disease

5(14.3)

3(21.4)

2(9.5)

0.37

 History of steroid and immunosuppressant within 1 month

8(22.9)

4(28.6)

4(19.0)

0.69

Pregnancy, number (%)

1(2.9)

0(0.0)

1(47.6)

1.00

Onset to NAI

9 ± 5

7 ± 3

11 ± 6

0.04*

Onset to ECMO

10 ± 3

10 ± 3

10 ± 3

0.97

Organ support pre-ECMO

 High-dose vasoactive drugsa, number (%)

20(57.1)

6(42.9)

14(63.6)

0.31

 Rescue ventilation strategiesb, number (%)

23(65.7)

6(43.9)

17(81.0)

0.03*

 Duration of IPPV, days, mean ± SD

5 ± 1

2 ± 1

6 ± 4

< 0.01*

SOFA Score

9 ± 3

7 ± 2

10 ± 4

0.02*

Murray Score

3.6 ± 0.4

3.6 ± 0.5

3.6 ± 0.4

0.95

PaO2/FiO2 pre-ECMO, mmHg, mean ± SD

78 ± 23

89 ± 24

71 ± 20

0.04*

Duration of ECMO, days, median (IQR)

8(5–13)

10(7–13)

7(3–16)

0.48

Total Duration of IPPV, days, mean ± SD

20 ± 8

23 ± 13

18 ± 15

0.36

Clinical outcomes

 Mortality, number (%)

22 (63)

1 (7.1)

21 (100)

< 0.01*

 Length of stay in ICU, days, mean ± SD

27 ± 14

33 ± 12

24 ± 14

0.081

 Length of hospitalization, days, mean ± SD

31 ± 14

39 ± 10

27 ± 14

0.010*

  1. Note: ahigh-dose vasoactive drugs [17] infer to: noradrenaline > 0.5 μg/kg/min or dopamine > 20 μg/kg/min; brescue ventilation strategies includes recruitment maneuver (RM), prone position ventilation (PP) and high frequency oscillatory ventilation (HFOV)
  2. NAI neuraminidase inhibitors, IPPV invasive positive pressure ventilation, ECMO extracorporeal membrane oxygenation, SOFA score sequential organ failure score, ICU intensive care unit
  3. We made comparison between successfully weaned and unsuccessfully weaned group using t-test, x2 test or Wilcoxon rank-sum test, and P values <0.05 were considered significant, marked as *